Stock price
Market cap
At each fiscal year end, then the latest quarter end: closing price × shares outstanding.
Show tableHide table
| Period | Market cap |
|---|---|
| FY2016, ended Sep 25, 2016 | $92.7B |
| FY2017, ended Sep 24, 2017 | $76.8B |
| FY2018, ended Sep 30, 2018 | $87.3B |
| FY2019, ended Sep 29, 2019 | $87.5B |
| FY2020, ended Sep 27, 2020 | $129B |
| FY2021, ended Sep 26, 2021 | $150B |
| FY2022, ended Sep 25, 2022 | $136B |
| FY2023, ended Sep 24, 2023 | $120B |
| FY2024, ended Sep 29, 2024 | $189B |
| FY2025, ended Sep 28, 2025 | $181B |
| Trailing 12 months to Jun 28, 2026 (through Q3 FY2026) | $199B |
Revenue
By fiscal year, then the trailing 12 months
Show tableHide table
| Period | Revenue |
|---|---|
| FY2016, ended Sep 25, 2016 | $23.6B |
| FY2017, ended Sep 24, 2017 | $22.3B |
| FY2018, ended Sep 30, 2018 | $22.6B |
| FY2019, ended Sep 29, 2019 | $24.3B |
| FY2020, ended Sep 27, 2020 | $23.5B |
| FY2021, ended Sep 26, 2021 | $33.6B |
| FY2022, ended Sep 25, 2022 | $44.2B |
| FY2023, ended Sep 24, 2023 | $35.8B |
| FY2024, ended Sep 29, 2024 | $39.0B |
| FY2025, ended Sep 28, 2025 | $44.3B |
| Trailing 12 months to Jun 28, 2026 (through Q3 FY2026) | $44.1B |
Net income and free cash flow
By fiscal year, then the trailing 12 months. Free cash flow is operating cash flow minus capex.
Show tableHide table
| Period | Net income | Free cash flow |
|---|---|---|
| FY2016, ended Sep 25, 2016 | $5.71B | $7.09B |
| FY2017, ended Sep 24, 2017 | $2.44B | $4.31B |
| FY2018, ended Sep 30, 2018 | −$4.96B | $3.12B |
| FY2019, ended Sep 29, 2019 | $4.39B | $6.40B |
| FY2020, ended Sep 27, 2020 | $5.20B | $4.41B |
| FY2021, ended Sep 26, 2021 | $9.04B | $8.65B |
| FY2022, ended Sep 25, 2022 | $12.9B | $6.83B |
| FY2023, ended Sep 24, 2023 | $7.23B | $9.85B |
| FY2024, ended Sep 29, 2024 | $10.1B | $11.2B |
| FY2025, ended Sep 28, 2025 | $5.54B | $12.8B |
| Trailing 12 months to Jun 28, 2026 (through Q3 FY2026) | $9.26B | $10.4B |
Cash and cash equivalents
At each fiscal year end, then the latest quarter end.
Show tableHide table
| Period | Cash and cash equivalents |
|---|---|
| FY2016, ended Sep 25, 2016 | $5.95B |
| FY2017, ended Sep 24, 2017 | $35.0B |
| FY2018, ended Sep 30, 2018 | $11.8B |
| FY2019, ended Sep 29, 2019 | $11.8B |
| FY2020, ended Sep 27, 2020 | $6.71B |
| FY2021, ended Sep 26, 2021 | $7.12B |
| FY2022, ended Sep 25, 2022 | $2.77B |
| FY2023, ended Sep 24, 2023 | $8.45B |
| FY2024, ended Sep 29, 2024 | $7.85B |
| FY2025, ended Sep 28, 2025 | $5.52B |
| Trailing 12 months to Jun 28, 2026 (through Q3 FY2026) | $4.53B |
Total debt
At each fiscal year end, then the latest quarter end. Short- and long-term borrowings, excluding leases.
Show tableHide table
| Period | Total debt |
|---|---|
| FY2016, ended Sep 25, 2016 | $10.0B |
| FY2017, ended Sep 24, 2017 | $20.4B |
| FY2018, ended Sep 30, 2018 | $16.4B |
| FY2019, ended Sep 29, 2019 | $13.9B |
| FY2020, ended Sep 27, 2020 | $15.7B |
| FY2021, ended Sep 26, 2021 | $14.2B |
| FY2022, ended Sep 25, 2022 | $14.0B |
| FY2023, ended Sep 24, 2023 | $14.5B |
| FY2024, ended Sep 29, 2024 | $13.3B |
| FY2025, ended Sep 28, 2025 | $14.8B |
| Trailing 12 months to Jun 28, 2026 (through Q3 FY2026) | $13.3B |
Shares outstanding
At each fiscal year end, then the latest quarter end, adjusted for splits. Down 28.9% since FY16.
Show tableHide table
| Period | Shares outstanding |
|---|---|
| FY2016, ended Sep 25, 2016 | 1.48B |
| FY2017, ended Sep 24, 2017 | 1.47B |
| FY2018, ended Sep 30, 2018 | 1.21B |
| FY2019, ended Sep 29, 2019 | 1.14B |
| FY2020, ended Sep 27, 2020 | 1.13B |
| FY2021, ended Sep 26, 2021 | 1.12B |
| FY2022, ended Sep 25, 2022 | 1.12B |
| FY2023, ended Sep 24, 2023 | 1.11B |
| FY2024, ended Sep 29, 2024 | 1.11B |
| FY2025, ended Sep 28, 2025 | 1.07B |
| Trailing 12 months to Jun 28, 2026 (through Q3 FY2026) | 1.05B |
Buybacks and new shares
By fiscal year, then the trailing 12 months, in dollars. Below zero: bought back. Above zero: issued to employees, sold or used in acquisitions.
Show tableHide table
| Period | Bought back | Paid to employees | Sold for cash |
|---|---|---|---|
| FY2016, ended Sep 25, 2016 | $3.92B | $943M | $668M |
| FY2017, ended Sep 24, 2017 | $1.34B | $914M | $497M |
| FY2018, ended Sep 30, 2018 | $22.6B | $883M | $603M |
| FY2019, ended Sep 29, 2019 | $1.79B | $1.04B | $414M |
| FY2020, ended Sep 27, 2020 | $2.45B | $1.21B | $329M |
| FY2021, ended Sep 26, 2021 | $3.37B | $1.66B | $347M |
| FY2022, ended Sep 25, 2022 | $3.13B | $2.03B | $356M |
| FY2023, ended Sep 24, 2023 | $2.97B | $2.48B | $434M |
| FY2024, ended Sep 29, 2024 | $4.12B | $2.65B | $383M |
| FY2025, ended Sep 28, 2025 | $8.79B | $2.78B | $404M |
| Trailing 12 months to Jun 28, 2026 (through Q3 FY2026) | $9.25B | $3.24B | $426M |
Valuation
At current price- Market Cap
- $193B
- P/E
- 20.9×
- Forward P/E
- —. Needs analyst estimates; not available from the current data provider
- Price / Sales
- 4.4×
- Price / Book
- 7.0×
- EV / EBITDA
- 17.1×
Growth
Trailing 12 months- Revenue (TTM)
- $44.1B
- Revenue Growth YoY
- 1.9%
- Revenue CAGR 3Y
- 0.1%
- Revenue CAGR 5Y
- 13.5%
- EPS Growth YoY
- −15.6%
- Net Income Growth YoY
- −20.0%
Profitability
Trailing 12 months- Gross Margin
- 54.2%
- Operating Margin
- 23.2%
- Net Margin
- 21.0%
- FCF Margin
- 23.6%
- Return on Equity
- 33.8%
Earnings
Trailing 12 months- Net Income
- $9.26B
- EPS (diluted)
- $8.75
- EBITDA
- $11.8B
- Operating Income
- $10.2B
Balance Sheet
As of Jun 28, 2026- Cash and cash equivalents
- $4.53B
- Total Debt
- $13.3B
- Net Debt
- $8.75B
- Total Assets
- $57.4B
- Total Liabilities
- $29.7B
- Shareholders' Equity
- $27.7B
Cash Flow
Trailing 12 months- Operating Cash Flow
- $12.4B
- Capital Expenditure
- $1.99B
- Free Cash Flow
- $10.4B
Dividends and risk
Last 12 months- Dividend Yield
- 2.0%
- Dividend / Share
- $3.62
- Beta (5Y)
- 1.64
Every ratio is calculated from the company’s reported figures.